IBRANCE : The life saving drug for metastatic breast cancerBreast Cancer

0 have signed. Let’s get to 5,000!


IBRANCE is a successful drug for treating metastatic breast cancer but this drug is currently not covered by the ON Cancer Agency and costs approximately $9,000 per month. Please help the metastatic patients in Ontario so they can be part of the success that this drug has been for so many others. 

The cost of the drug is putting tremendous strain on cancer patients and their families at a time when they should be avoiding stress as much as possible. A great majority of patients simply can’t afford it. This is a tragedy!

It shouldn’t be a lottery to decide which drugs are covered and which ones aren’t or who has coverage and who does not. IBrance has been approved by Health Canada and shows so much promise. Ontario is a leader in cancer care and should be funding this life saving drug. 

EXCITING NEWS!!
February 2018

CONGRATULATIONS to the provinces of Quebec, New Brunswick and Saskatchewan for getting on board and adding Ibrance made by Pfizer to your drug formulary! Thank you for stepping up and supporting the needs of the women of your Province with Metastatic Breast Cancer!!!

Can Ontario follow suit? It would be tremendous and give hope to the metastatic breast cancer patients who are running out of options in Ontario. 

Thank you. 



Today: Karen is counting on you

Karen Osborne needs your help with “hlth.minister@gov.on.ca hjaczec.mpp@liberal.ola.org: IBRANCE : The life saving drug for metastatic breast cancerBreast Cancer”. Join Karen and 4,076 supporters today.